Posted in | News | Medical Optics

ThermoGenesis Signs Deal with Concessus for Distributing AXP and Bioarchive Systems

ThermoGenesis has signed a four-year deal with Concessus for distributing BioArchive and AXP AutoXpress (AXP) Systems in a select number of West-European countries.

The countries include Liechtenstein, Nordic countries, Benelux, Switzerland, Spain and France. The BioArchive System is a robotic device which deals with storage, retrieval and cryopreservation of cord blood and stem cell samples. The AXP AutoXpress System is a set of automated devices for harvesting stem cells and cord blood cells in a closed system.

ThermoGenesis’ Chief Executive Officer, Matthew Plavan, said that this deal reflected the company’s growth in the international scene of cord blood market, with the additional approvals granted by China and Thailand for the BioArchive and AXP products, respectively. He also expressed his pleasure in the expansion of the company’s association with Concessus which is well-known for the distribution of healthcare products in Western Europe.

Concessus, which deals with diagnostic laboratory equipment in the field of healthcare, is based in Lisbon. Prior to this deal with ThermoGenesis, Concessus was already distributing BioArchive System since the year 2010. Chief Executive Officer of Concessus, João Araújo, said that the distribution of AXP System in addition to the BioArchive System will act as an advantage in the competitive market of cord blood products in the regions of Western Europe. He also felt proud in citing that in Western Europe, Concessus was the sole company dealing with completely automated cell storage and cell processing services and products.

Hal Baker, who is the Head of Commercial Operations in ThermoGenesis, said that this deal involves a customer-centric approach for marketing both the cord blood products through the same partner company. He felt that this was a significant development towards the company’s expansion in the cord blood market.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 27). ThermoGenesis Signs Deal with Concessus for Distributing AXP and Bioarchive Systems. AZoOptics. Retrieved on November 23, 2024 from https://www.azooptics.com/News.aspx?newsID=16063.

  • MLA

    Thomas, G.P.. "ThermoGenesis Signs Deal with Concessus for Distributing AXP and Bioarchive Systems". AZoOptics. 23 November 2024. <https://www.azooptics.com/News.aspx?newsID=16063>.

  • Chicago

    Thomas, G.P.. "ThermoGenesis Signs Deal with Concessus for Distributing AXP and Bioarchive Systems". AZoOptics. https://www.azooptics.com/News.aspx?newsID=16063. (accessed November 23, 2024).

  • Harvard

    Thomas, G.P.. 2019. ThermoGenesis Signs Deal with Concessus for Distributing AXP and Bioarchive Systems. AZoOptics, viewed 23 November 2024, https://www.azooptics.com/News.aspx?newsID=16063.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.